MANGALAM GLOBAL ENTERPRISE
Back to Balance Sheet
|
MANGALAM GLOBAL ENTERPRISE Last 5 Year Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Current Liabilities | - | - | - | - | - |
What is the latest Current Liabilities ratio of MANGALAM GLOBAL ENTERPRISE ?
| Year | Current Liabilities |
|---|---|
| Mar2025 | - |
| Mar2024 | - |
| Mar2023 | - |
| Mar2022 | - |
| Mar2021 | - |
How is Current Liabilities of MANGALAM GLOBAL ENTERPRISE Trending?
| Years | Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | - | 0 | |
| Mar2024 | - | 0 | |
| Mar2023 | - | 0 | |
| Mar2022 | - | 0 | |
| Mar2021 | - | - | |
Compare Current Liabilities of peers of MANGALAM GLOBAL ENTERPRISE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANGALAM GLOBAL ENTERPRISE | ₹328.3 Cr | -2.5% | -21.6% | -34.2% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹10,447.6 Cr | -4.1% | -17.5% | -10.9% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,178.7 Cr | 0.7% | -10% | -23.7% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,716.8 Cr | -6.2% | -17.1% | -25% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹856.3 Cr | -2.9% | -8.7% | -38.8% | Stock Analytics | |
| INDO US BIOTECH | ₹200.5 Cr | -0.6% | -21.5% | -48.6% | Stock Analytics | |
MANGALAM GLOBAL ENTERPRISE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANGALAM GLOBAL ENTERPRISE | -2.5% |
-21.6% |
-34.2% |
| SENSEX | -2.7% |
-10.4% |
1.6% |
You may also like the below Video Courses